ACM
BMY icon

Allred Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Allred Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$445K Buy
7,331
+25
+0.3% +$1.46K 0.16% 110
2025
Q4 		$394K Buy
7,306
+23
+0.3% +$1.11K 0.14% 116
2025
Q3 		$328K Sell
7,283
-65
-0.9% -$3.04K 0.11% 134
2025
Q2 		$340K Sell
7,348
-558
-7% -$27.4K 0.13% 124
2025
Q1 		$482K Sell
7,906
-64
-0.8% -$3.73K 0.19% 102
2024
Q4 		$451K Buy
7,970
+7
+0.1% +$391 0.17% 115
2024
Q3 		$412K Sell
7,963
-756
-9% -$35.5K 0.16% 117
2024
Q2 		$362K Sell
8,719
-546
-6% -$24.4K 0.14% 130
2024
Q1 		$502K Sell
9,265
-877
-9% -$44.7K 0.2% 109
2023
Q4 		$520K Buy
10,142
+1,088
+12% +$57.1K 0.23% 94
2023
Q3 		$526K Buy
9,054
+26
+0.3% +$1.59K 0.26% 84
2023
Q2 		$577K Buy
9,028
+72
+0.8% +$4.83K 0.28% 75
2023
Q1 		$621K Sell
8,956
-24
-0.3% -$1.69K 0.33% 63
2022
Q4 		$646K Sell
8,980
-137
-2% -$10.3K 0.35% 63
2022
Q3 		$648K Sell
9,117
-82
-0.9% -$5.95K 0.4% 55
2022
Q2 		$708K Sell
9,199
-640
-7% -$48.7K 0.45% 56
2022
Q1 		$718K Buy
9,839
+102
+1% +$6.85K 0.38% 66
2021
Q4 		$607K Buy
9,737
+315
+3% +$18.5K 0.29% 87
2021
Q3 		$558K Sell
9,422
-759
-7% -$50K 0.29% 89
2021
Q2 		$680K Sell
10,181
-284
-3% -$18.5K 0.34% 77
2021
Q1 		$661K Sell
10,465
-1,497
-13% -$93.1K 0.3% 76
2020
Q4 		$742K Sell
11,962
-46
-0.4% -$2.83K 0.41% 65
2020
Q3 		$723K Buy
12,008
+1,222
+11% +$73.5K 0.44% 65
2020
Q2 		$634K Sell
10,786
-762
-7% -$45.6K 0.4% 65
2020
Q1 		$643K Buy
11,548
+110
+1% +$6.72K 0.5% 56
2019
Q4 		$734K Buy
11,438
+40
+0.4% +$2.29K 0.4% 60
2019
Q3 		$577K Buy
11,398
+1,184
+12% +$55.6K 0.35% 78
2019
Q2 		$476K Sell
10,214
-379
-4% -$17.7K 0.27% 99
2019
Q1 		$495K Buy
10,593
+624
+6% +$31.1K 0.28% 96
2018
Q4 		$518K Buy
+9,969
New +$536K 0.35% 91

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Allred Capital Management's BMY Position: Q1 2026 in Review

Allred Capital Management increased its Bristol-Myers Squibb (BMY) stake by 0.34% in Q1 2026, buying an estimated $1.46K and bringing the position to 7,331 shares worth $445K. The position accounts for 0.16% of the portfolio, ranked #110.

Allred Capital Management first reported a position in BMY in Q4 2018 and has held it in 30 quarters since. The position peaked at $742K in Q4 2020. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Allred Capital Management held 7,331 shares of Bristol-Myers Squibb worth $445K as of Q1 2026.
  • Allred Capital Management bought 25 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.46K.
  • Bristol-Myers Squibb made up 0.16% of Allred Capital Management's portfolio in Q1 2026, its #110 holding.
  • Allred Capital Management first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 30 quarters since.
  • Allred Capital Management's Bristol-Myers Squibb position peaked at $742K in Q4 2020.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Allred Capital Management's 13F filing for Q1 2026, filed 14 May 2026.